These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 7696960)

  • 1. Hematopathology of interleukin 6-type cytokines.
    Hawley RG
    Stem Cells; 1994; 12 Suppl 1():155-71. PubMed ID: 7696960
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Signal transduction through gp130 that is shared among the receptors for the interleukin 6 related cytokine subfamily.
    Hirano T; Matsuda T; Nakajima K
    Stem Cells; 1994 May; 12(3):262-77. PubMed ID: 8075593
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The cytokine receptor gp130: faithfully promiscuous.
    Müller-Newen G
    Sci STKE; 2003 Sep; 2003(201):PE40. PubMed ID: 14506288
    [TBL] [Abstract][Full Text] [Related]  

  • 4. gp130 and the IL-6 family of cytokines: signaling mechanisms and thrombopoietic activities.
    Nakashima K; Taga T
    Semin Hematol; 1998 Jul; 35(3):210-21. PubMed ID: 9685167
    [TBL] [Abstract][Full Text] [Related]  

  • 5. FR901228, an inhibitor of histone deacetylases, increases the cellular responsiveness to IL-6 type cytokines by enhancing the expression of receptor proteins.
    Blanchard F; Kinzie E; Wang Y; Duplomb L; Godard A; Held WA; Asch BB; Baumann H
    Oncogene; 2002 Sep; 21(41):6264-77. PubMed ID: 12214267
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of soluble gp130 released by melanoma cell lines: A polyvalent antagonist of cytokines from the interleukin 6 family.
    Montero-Julian FA; Brailly H; Sautès C; Joyeux I; Dorval T; Mosseri V; Yasukawa K; Wijdenes J; Adler A; Gorin I; Fridman WH; Tartour E
    Clin Cancer Res; 1997 Aug; 3(8):1443-51. PubMed ID: 9815830
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interleukin 11: an overview.
    Yang YC
    Stem Cells; 1993 Nov; 11(6):474-86. PubMed ID: 8111307
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The human IL-11 receptor requires gp130 for signalling: demonstration by molecular cloning of the receptor.
    Nandurkar HH; Hilton DJ; Nathan P; Willson T; Nicola N; Begley CG
    Oncogene; 1996 Feb; 12(3):585-93. PubMed ID: 8637716
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation of the signal transducer glycoprotein 130 by both IL-6 and IL-11 requires two distinct binding epitopes.
    Kurth I; Horsten U; Pflanz S; Dahmen H; Küster A; Grötzinger J; Heinrich PC; Müller-Newen G
    J Immunol; 1999 Feb; 162(3):1480-7. PubMed ID: 9973404
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interleukin-11 and its receptor.
    Yang YC; Yin T
    Biofactors; 1992 Dec; 4(1):15-21. PubMed ID: 1292471
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Growth regulatory pathways in myeloma. Evidence for autocrine oncostatin M expression.
    Westendorf JJ; Jelinek DF
    J Immunol; 1996 Oct; 157(7):3081-8. PubMed ID: 8816418
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IL-6 signal transduction and its physiological roles: the signal orchestration model.
    Kamimura D; Ishihara K; Hirano T
    Rev Physiol Biochem Pharmacol; 2003; 149():1-38. PubMed ID: 12687404
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interleukin-6-type cytokines stimulate mesenchymal progenitor differentiation toward the osteoblastic lineage.
    Taguchi Y; Yamamoto M; Yamate T; Lin SC; Mocharla H; DeTogni P; Nakayama N; Boyce BF; Abe E; Manolagas SC
    Proc Assoc Am Physicians; 1998; 110(6):559-74. PubMed ID: 9824538
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunohistochemical analysis of the IL-6 family of cytokines and their receptors in benign, hyperplasic, and malignant human prostate.
    Royuela M; Ricote M; Parsons MS; García-Tuñón I; Paniagua R; de Miguel MP
    J Pathol; 2004 Jan; 202(1):41-9. PubMed ID: 14694520
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of bone marrow stromal cell differentiation by cytokines whose receptors share the gp130 protein.
    Gimble JM; Wanker F; Wang CS; Bass H; Wu X; Kelly K; Yancopoulos GD; Hill MR
    J Cell Biochem; 1994 Jan; 54(1):122-33. PubMed ID: 8126083
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The interleukin-6 signal transducer, gp130, functioning in immune, hematopoietic, and neural systems].
    Taga T
    Nihon Rinsho; 1992 Aug; 50(8):1802-10. PubMed ID: 1433971
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of pre-B cell colony-enhancing factor by STAT-3-dependent interleukin-6 trans-signaling: implications in the pathogenesis of rheumatoid arthritis.
    Nowell MA; Richards PJ; Fielding CA; Ognjanovic S; Topley N; Williams AS; Bryant-Greenwood G; Jones SA
    Arthritis Rheum; 2006 Jul; 54(7):2084-95. PubMed ID: 16802343
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CNTF/LIF/gp130 receptor complex signaling maintains a VZ precursor differentiation gradient in the developing ventral forebrain.
    Gregg C; Weiss S
    Development; 2005 Feb; 132(3):565-78. PubMed ID: 15634701
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Are LIF and related cytokines functionally equivalent?
    Piquet-Pellorce C; Grey L; Mereau A; Heath JK
    Exp Cell Res; 1994 Aug; 213(2):340-7. PubMed ID: 8050491
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interleukin-6 receptor antagonists inhibit interleukin-11 biological activity.
    Sun RX; Gennaro C; Rocco S; Gu ZJ; Klein B
    Eur Cytokine Netw; 1997 Mar; 8(1):51-6. PubMed ID: 9110148
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.